These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28717701)

  • 1. Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors.
    Tan G; Zhou K; Tan CH; Matchar DB; Farid M; Quek R; Ngeow J
    J Glob Oncol; 2016 Aug; 2(4):186-199. PubMed ID: 28717701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
    Day FL; Karnon J; Rischin D
    J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.
    Hwang JP; Huang D; Vierling JM; Suarez-Almazor ME; Shih YT; Chavez-MacGregor M; Duan Z; Giordano SH; Hershman DL; Fisch MJ; Cantor SB
    JCO Clin Cancer Inform; 2019 Mar; 3():1-12. PubMed ID: 30892921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.
    Wong WW; Hicks LK; Tu HA; Pritchard KI; Krahn MD; Feld JJ; Chan KK
    Breast Cancer Res Treat; 2015 Jun; 151(3):639-52. PubMed ID: 25962692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Screening for Hepatitis B Virus Infection in Patients With Solid Tumors Before Initiating Chemotherapy.
    Konijeti GG; Grandhe S; Tincopa M; Lane JA; Shrime MG; Singh S; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1600-1608.e4. PubMed ID: 31678602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
    Zurawska U; Hicks LK; Woo G; Bell CM; Krahn M; Chan KK; Feld JJ
    J Clin Oncol; 2012 Sep; 30(26):3167-73. PubMed ID: 22711851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
    Zhang P; Yang Y; Wen F; Wheeler J; Fu P; Li Q
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1978-1985. PubMed ID: 27118432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
    Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
    Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW; Woo G; Jenny Heathcote E; Krahn M
    Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.
    Day FL; Link E; Thursky K; Rischin D
    J Oncol Pract; 2011 May; 7(3):141-7. PubMed ID: 21886492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma.
    Fujita M; Kusumoto S; Ishii I; Iwata T; Fujisawa T; Sugiyama M; Hata A; Mizokami M
    Sci Rep; 2022 May; 12(1):7365. PubMed ID: 35513395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine for the treatment of chronic hepatitis B infection.
    Hartwell D; Jones J; Harris P; Cooper K
    Health Technol Assess; 2009 Oct; 13 Suppl 3():23-30. PubMed ID: 19846025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre.
    Selvapatt N; Ward T; Bailey H; Bennett H; Thorne C; See LM; Tudor-Williams G; Thursz M; McEwan P; Brown A
    J Hepatol; 2015 Oct; 63(4):797-804. PubMed ID: 26024832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
    Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
    Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.